Calysta CEO and leadership

Alan Shaw is a Special Advisor at CODEXIS, INC.; Co-Founder, President & CEO, Board at Calysta; and Board Member at Calysta and is based in Menlo Park, California. He has worked as Sr Operating & Bus Dev Positions at Chiroscience Group Ltd; Founder, President & CEO, Board at CODEXIS, INC.; and Business Head, Fine Chemicals & Marketing Mgr, European Sales at Imperial Chemical Industries(ICI) / Zeneca. Alan works or has worked as FELLOW at CIM - The Chartered Institute of Marketing, BOARD MEMBER at Biotechnology Industry Trade Assn, and FELLOW at Royal Society of Chemistry. He studied at Teesside University between 1983 and 1986 and Durham University between 1986 and 1989.

Josh Silverman, Ph.D. is the co-Founder and Chief Scientific Officer of Calysta Energy™. Dr. Silverman is an experienced biotechnology entrepreneur with a history of successful development of novel technology platforms. Prior to founding Calysta Energy™, Dr. Silverman has held positions at two public biotechnology companies, Maxygen, Inc. and Amgen, Inc. as well as serving as VP of Product development for Amunix, Inc. In addition, he has been involved in the founding and financing of five startup biotechnology companies (Avidia, Versartis, Diartis, Siluria, and Calysta). His efforts have contributed to raising over $110M in equity financing across these companies, as well as the sale of Avidia for $290M three years after founding the company. Dr. Silverman is generally interested in tools and applications of biological engineering as a robust and predictable engineering discipline. He serves as an advisor for a number of biotechnology companies and is a frequent speaker at scientific meetings. He is an author on more than 10 scientific publications as well as over 30 patents and pending patent applications. He received his B.Sc. in Molecular Biology from UC San Diego and Ph.D. in Biochemistry from Stanford University.

Geoff Bryant is a Chief Technology Officer at Calysta and is based in Harrogate, North Yorkshire, United Kingdom. He has worked as VP R&D, The Nutro Company (Mars Natural Petcare business unit) at Mars Petcare; Technical and Innovation Director at Quorn Foods; and Group Innovation Director at Baxters. Geoff attended London Business School between 2008 and 2008, Centre for Creative Leadership, and UNIVERSITY OF EAST ANGLIA between 1987 and 1993.

Thomas Huot is a Board Member at Genomatica, Chief Operating Officer at Calysta, and Partner at VantagePoint Venture Partners and is based in Menlo Park, California. He has worked as Analyst at CDP Capital Technology Ventures, Managing Director at VantagePoint Venture Partners, and Project Manager at Genopole. Thomas attended University of London, University of Paris Sud (University of Paris XI), and University of Paris-Sud XI.

Alan Shaw is a Special Advisor at CODEXIS, INC.; Co-Founder, President & CEO, Board at Calysta; and Board Member at Calysta and is based in Menlo Park, California. He has worked as Sr Operating & Bus Dev Positions at Chiroscience Group Ltd; Founder, President & CEO, Board at CODEXIS, INC.; and Business Head, Fine Chemicals & Marketing Mgr, European Sales at Imperial Chemical Industries(ICI) / Zeneca. Alan works or has worked as FELLOW at CIM - The Chartered Institute of Marketing, BOARD MEMBER at Biotechnology Industry Trade Assn, and FELLOW at Royal Society of Chemistry. He studied at Teesside University between 1983 and 1986 and Durham University between 1986 and 1989.

Josh Silverman, Ph.D. is the co-Founder and Chief Scientific Officer of Calysta Energy™. Dr. Silverman is an experienced biotechnology entrepreneur with a history of successful development of novel technology platforms. Prior to founding Calysta Energy™, Dr. Silverman has held positions at two public biotechnology companies, Maxygen, Inc. and Amgen, Inc. as well as serving as VP of Product development for Amunix, Inc. In addition, he has been involved in the founding and financing of five startup biotechnology companies (Avidia, Versartis, Diartis, Siluria, and Calysta). His efforts have contributed to raising over $110M in equity financing across these companies, as well as the sale of Avidia for $290M three years after founding the company. Dr. Silverman is generally interested in tools and applications of biological engineering as a robust and predictable engineering discipline. He serves as an advisor for a number of biotechnology companies and is a frequent speaker at scientific meetings. He is an author on more than 10 scientific publications as well as over 30 patents and pending patent applications. He received his B.Sc. in Molecular Biology from UC San Diego and Ph.D. in Biochemistry from Stanford University.

Alan Shaw is a Special Advisor at CODEXIS, INC.; Co-Founder, President & CEO, Board at Calysta; and Board Member at Calysta and is based in Menlo Park, California. He has worked as Sr Operating & Bus Dev Positions at Chiroscience Group Ltd; Founder, President & CEO, Board at CODEXIS, INC.; and Business Head, Fine Chemicals & Marketing Mgr, European Sales at Imperial Chemical Industries(ICI) / Zeneca. Alan works or has worked as FELLOW at CIM - The Chartered Institute of Marketing, BOARD MEMBER at Biotechnology Industry Trade Assn, and FELLOW at Royal Society of Chemistry. He studied at Teesside University between 1983 and 1986 and Durham University between 1986 and 1989.